Ephedrine Sulfate Injection
Product Images NDC 71872-7257

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ephedrine Sulfate (NDC 71872-7257). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7257-01.pdp (71872 7257 01)

71872-7257-01.pdp (71872 7257 01)
This is a description of a medication, Ephedrine Sulfate Injection, USP, that is sold in a 1 mL single-dose vial with a concentration of 50 mg/mL. The medication is manufactured by Amneal Pharmaceuticals Pvt Ltd in India and distributed by Amneal Pharmaceuticals LLC in the US. The vial stoppers are not made of natural rubber latex. The medication must be diluted and is intended for intravenous use. Each mL contains ephedrine sulfate, which is equivalent to 38 mg of ephedrine base, and water for injection, with a pH adjusted with either sodium hydroxide and/or acetic acid if necessary. The direction for use is provided in the package insert. The vial should be stored at 20° to 25°C (68° to 77°F) but excursions up to 30°C (86°F) are permitted. The information also includes the lot number, expiration date, and the fact that any unused portion should be discarded.*
FDA Label Image

L (Ephedrine Sulfate Injection 1)

FDA Label Image

1 (Ephedrine Sulfate Injection 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.